569 related articles for article (PubMed ID: 29206641)
1. Comparison of exercise training responses in COPD patients with and without Alpha-1 antitrypsin deficiency.
Jarosch I; Hitzl W; Koczulla AR; Wencker M; Welte T; Gloeckl R; Janciauskiene S; Kenn K
Respir Med; 2017 Sep; 130():98-101. PubMed ID: 29206641
[TBL] [Abstract][Full Text] [Related]
2. Different Training-Induced Skeletal Muscle Adaptations in COPD Patients with and without Alpha-1 Antitrypsin Deficiency.
Jarosch I; Gehlert S; Jacko D; Koczulla RA; Wencker M; Welte T; Bloch W; Janciauskiene S; Kenn K
Respiration; 2016; 92(5):339-347. PubMed ID: 27686000
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of Alpha-1 Antitrypsin-Deficient Individuals in the Long-term Oxygen Treatment Trial and Comparison with Other Subjects with Chronic Obstructive Pulmonary Disease.
Stoller JK; Aboussouan LS; Kanner RE; Wilson LA; Diaz P; Wise R;
Ann Am Thorac Soc; 2015 Dec; 12(12):1796-804. PubMed ID: 26653189
[TBL] [Abstract][Full Text] [Related]
4. PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD.
Green CE; Vayalapra S; Hampson JA; Mukherjee D; Stockley RA; Turner AM
Thorax; 2015 Oct; 70(10):939-45. PubMed ID: 26141072
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory cytokine response to exercise in alpha-1-antitrypsin deficient COPD patients 'on' or 'off' augmentation therapy.
Olfert IM; Malek MH; Eagan TM; Wagner H; Wagner PD
BMC Pulm Med; 2014 Jun; 14():106. PubMed ID: 24975928
[TBL] [Abstract][Full Text] [Related]
6. The natural history of lung function after lung transplantation for α(1)-antitrypsin deficiency.
Banga A; Gildea T; Rajeswaran J; Rokadia H; Blackstone EH; Stoller JK
Am J Respir Crit Care Med; 2014 Aug; 190(3):274-81. PubMed ID: 25003824
[TBL] [Abstract][Full Text] [Related]
7. Is an integrative laboratory algorithm more effective in detecting alpha-1-antitrypsin deficiency in patients with premature chronic obstructive pulmonary disease than AAT concentration based screening approach?
Beletic A; Dudvarski-Ilic A; Milenkovic B; Nagorni-Obradovic L; Ljujic M; Djordjevic V; Mirkovic D; Radojkovic D; Majkic-Singh N
Biochem Med (Zagreb); 2014; 24(2):293-8. PubMed ID: 24969923
[TBL] [Abstract][Full Text] [Related]
8. Advances in managing COPD related to α
Craig TJ; Henao MP
Allergy; 2018 Nov; 73(11):2110-2121. PubMed ID: 29984428
[TBL] [Abstract][Full Text] [Related]
9. Exacerbations and duration of smoking abstinence are associated with the annual loss of FEV
Fähndrich S; Bernhard N; Lepper PM; Vogelmeier C; Seibert M; Wagenpfeil S; Bals R
Respir Med; 2017 Aug; 129():8-15. PubMed ID: 28732839
[TBL] [Abstract][Full Text] [Related]
10. The important role of primary care providers in the detection of alpha-1 antitrypsin deficiency.
Lascano JE; Campos MA
Postgrad Med; 2017 Nov; 129(8):889-895. PubMed ID: 28929906
[TBL] [Abstract][Full Text] [Related]
11. Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis Study. Alpha-1 Protocol.
Strange C; Senior RM; Sciurba F; O'Neal S; Morris A; Wisniewski SR; Bowler R; Hochheiser HS; Becich MJ; Zhang Y; Leader JK; Methé BA; Kaminski N; Sandhaus RA;
Ann Am Thorac Soc; 2015 Oct; 12(10):1551-60. PubMed ID: 26153726
[TBL] [Abstract][Full Text] [Related]
12. Predictors of success for pulmonary rehabilitation in patients awaiting lung transplantation.
Kenn K; Gloeckl R; Soennichsen A; Sczepanski B; Winterkamp S; Boensch M; Welte T
Transplantation; 2015 May; 99(5):1072-7. PubMed ID: 25393161
[TBL] [Abstract][Full Text] [Related]
13. Testing for alpha-1 antitrypsin in COPD in outpatient respiratory clinics in Spain: A multilevel, cross-sectional analysis of the EPOCONSUL study.
Calle Rubio M; Soriano JB; López-Campos JL; Soler-Cataluña JJ; Alcázar Navarrete B; Rodríguez González-Moro JM; Miravitlles M; Barrecheguren M; Fuentes Ferrer ME; Rodriguez Hermosa JL;
PLoS One; 2018; 13(6):e0198777. PubMed ID: 29953442
[TBL] [Abstract][Full Text] [Related]
14. Clarifying the Risk of Lung Disease in SZ Alpha-1 Antitrypsin Deficiency.
Franciosi AN; Hobbs BD; McElvaney OJ; Molloy K; Hersh C; Clarke L; Gunaratnam C; Silverman EK; Carroll TP; McElvaney NG
Am J Respir Crit Care Med; 2020 Jul; 202(1):73-82. PubMed ID: 32197047
[No Abstract] [Full Text] [Related]
15. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
Rahaghi FF; Miravitlles M
Respir Res; 2017 May; 18(1):105. PubMed ID: 28558837
[TBL] [Abstract][Full Text] [Related]
16. Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update.
Casas F; Blanco I; Martínez MT; Bustamante A; Miravitlles M; Cadenas S; Hernández JM; Lázaro L; Rodríguez E; Rodríguez-Frías F; Torres M; Lara B
Arch Bronconeumol; 2015 Apr; 51(4):185-92. PubMed ID: 25027067
[TBL] [Abstract][Full Text] [Related]
17. Alpha-1 Antitrypsin Deficiency in COPD Patients: A Cross-Sectional Study.
Sorroche PB; Fernández Acquier M; López Jove O; Giugno E; Pace S; Livellara B; Legal S; Oyhamburu J; Saez MS
Arch Bronconeumol; 2015 Nov; 51(11):539-43. PubMed ID: 25800328
[TBL] [Abstract][Full Text] [Related]
18. Bronchoscopic Lung Volume Reduction in Patients with Emphysema due to Alpha-1 Antitrypsin Deficiency.
Everaerts S; Hartman JE; Van Dijk M; Koster TD; Slebos DJ; Klooster K
Respiration; 2023; 102(2):134-142. PubMed ID: 36549279
[TBL] [Abstract][Full Text] [Related]
19. Gene and miRNA expression profiles in PBMCs from patients with severe and mild emphysema and PiZZ alpha1-antitrypsin deficiency.
Esquinas C; Janciauskiene S; Gonzalo R; Mas de Xaxars G; Olejnicka B; Belmonte I; Barrecheguren M; Rodriguez E; Nuñez A; Rodriguez-Frias F; Miravitlles M
Int J Chron Obstruct Pulmon Dis; 2017; 12():3381-3390. PubMed ID: 29238183
[TBL] [Abstract][Full Text] [Related]
20. Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review.
Edgar RG; Patel M; Bayliss S; Crossley D; Sapey E; Turner AM
Int J Chron Obstruct Pulmon Dis; 2017; 12():1295-1308. PubMed ID: 28496314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]